Krabbe Disease Global Patient Registry
The Institute for Myelin and Glia Exploration's Clinical Database of Patients With Krabbe Disease, A World-Wide Registry
State University of New York at Buffalo
60 participants
Sep 1, 2014
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to develop a clinical database of individuals diagnosed with Krabbe disease in order to determine which symptoms herald the onset of clinical disease in the various phenotypes of Krabbe disease; to determine whether level of GALC enzyme activity, or a specific genetic mutation predict the clinical course; and to determine which neurodiagnostic tests predict onset and/or severity of the disease.
Eligibility
Inclusion Criteria3
- Anyone diagnosed with Krabbe disease
- Anyone at-risk for Krabbe disease
- Family members of someone diagnosed with, or at-risk for, Krabbe disease.
Exclusion Criteria2
- Anyone who is not diagnosed with, or at-risk for, Krabbe disease
- Anyone who is not a family member of someone diagnosed with, or at-risk for, Krabbe disease
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02993796